awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q36106412-0AA31916-13FB-451B-B510-B7C906F8E64B
Q36106412-0AA31916-13FB-451B-B510-B7C906F8E64B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36106412-0AA31916-13FB-451B-B510-B7C906F8E64B
A phase 1 study of a heterologous prime-boost vaccination involving a truncated HER2 sequence in patients with HER2-expressing breast cancer.
P2860
Q36106412-0AA31916-13FB-451B-B510-B7C906F8E64B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36106412-0AA31916-13FB-451B-B510-B7C906F8E64B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7ca3f58dfaff4446a572b762676a30a8d5e7665d
P2860
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.